Related Experiment Video

Updated: Aug 7, 2026

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Antibody-directed enzyme prodrug therapy for cancer: its theoretical basis and application

K D Bagshawe1

  • 1Department of Surgery, Charing Cross and Westminster Medical School, London, UK.

Molecular Medicine Today
|December 1, 1995
PubMed

Insights

Researchers developed a novel cancer therapy where a prodrug is activated into a cytotoxic agent specifically at tumor sites. This targeted approach uses an enzyme delivered by an antibody, enhancing drug concentration where needed.

Area of Science:

  • Biotechnology
  • Oncology
  • Drug Delivery Systems

Background:

  • Selective systemic cancer agents remain a significant challenge in oncology.
  • Nonselective cytotoxic drugs require targeted delivery to effectively eradicate tumors.
  • Achieving sufficient drug concentration at cancer sites without systemic toxicity is difficult.

Purpose of the Study:

  • To demonstrate a novel approach for selective cancer cell targeting.
  • To generate cytotoxic agents directly at tumor sites from a prodrug.
  • To utilize antibody-delivered enzymes for targeted prodrug activation.

Main Methods:

  • Antibodies were engineered to deliver specific enzymes to cancer sites.
  • A low-toxicity prodrug was administered systemically.
  • Enzyme-prodrug combinations were tested for targeted cytotoxic agent generation.

Main Results:

  • The feasibility of generating cytotoxic agents selectively at cancer sites was demonstrated.
  • Successful application was shown across various enzyme-prodrug combinations.
  • This method allows for localized activation of potent anti-cancer drugs.

Conclusions:

  • This antibody-directed enzyme-prodrug therapy offers a promising strategy for targeted cancer treatment.
  • The approach overcomes limitations of traditional nonselective cytotoxic chemotherapy.
  • Further development could lead to more effective and less toxic cancer therapies.

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...